A dual therapy of nanostructured lipid carrier loaded with teriflunomide—a dihydro-orotate dehydrogenase inhibitor and an mir-155-antagomir in cuprizone-induced c57bl/6j mouse

HIGHLIGHTS

  • who: Trideva Sastri Koduru and collaborators from the Department of, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Shivarathreeshwara Nagara, Mysuru, India School of Pharmacy, Sri Balaji Vidyapeeth (Deemed to be University), Puducherry, India have published the research work: A Dual Therapy of Nanostructured Lipid Carrier Loaded with Teriflunomideu2014A Dihydro-Orotate Dehydrogenase Inhibitor and an miR-155-Antagomir in Cuprizone-Induced C57BL/6J Mouse, in the Journal: Pharmaceutics 2023, 1254 of /2023/
  • what: The authors investigated the potential of nanocarrier systems to deliver miR-155antagomir-teriflunomide (TEF) therapy to the brain via . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?